Clik here to view.
After Cardiac Transplantation: Sirolimus acts as immunosuppressant Attenuates...
After Cardiac Transplantation: Sirolimus acts as immunosuppressant Attenuates Allograft Vasculopathy Writer and Curator: Larry H Bernstein, MD, FCAP and Curator: Aviva Lev-Ari, PhD, RN Sirolimus as...
View ArticleClik here to view.
Heart Transplantation: NHLBI’s Ten year Strategic Research Plan to Achieving...
Heart Transplantation: NHLBI’s Ten year Strategic Research Plan to Achieving Evidence-based Outcomes Writer and Curator: Larry H Bernstein, MD, FCAP and Curator: Aviva Lev-Ari, PhD, RN Heart...
View ArticleClik here to view.
Mechanical Circulatory Support System, LVAD, RVAD, Biventricular as a Bridge...
Mechanical Circulatory Assist Devices as a Bridge to Heart Transplantation or as “Destination Therapy“: Options for Patients in Advanced Heart Failure Writer and Curator: Larry H. Bernstein, MD, FCAP...
View ArticleClik here to view.
Heart Transplant (HT) Indication for Heart Failure (HF): Procedure Outcomes...
Heart Transplant (HT) Indication for Heart Failure (HF) – Procedure Outcomes and Research on HF, HT @ Two Nation’s Leading HF & HT Centers: Center for Heart Failure @Cleveland Clinic, and...
View ArticleClik here to view.
Alternative Designs for the Human Artificial Heart: The Patients in Heart...
Alternative Designs for the Human Artificial Heart: The Patients in Heart Failure – Outcomes of Transplant (donor)/Implantation (artificial) and Monitoring Technologies for the Transplant/Implant...
View ArticlePatient Shares Story: Hep C Heart Transplant
Reporter: Gail S. Thornton This article appeared on the website of Cardiovascular Business. ‘Patient No. 1’ from a Hep C heart transplant study shares his story March 07, 2019 Daniel Allar Tom...
View Article
